Ubs Group Ag CONTRAVIR PHARMACEUTICALS IN Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
N/A
-10,000 Closed
0 $0
Q1 2018

May 15, 2018
SELL
N/A
-2,170 Reduced 17.83%
10,000 $2,000
Q4 2017

Feb 14, 2018
SELL
N/A
-21,825 Reduced 64.2%
12,170 $4,000
Q3 2017

Nov 14, 2017
BUY
N/A
4,511 Added 15.3%
33,995 $18,000
Q2 2017

Aug 14, 2017
BUY
N/A
29,484
29,484 $17,000
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email